EGR2 and type 2 diabetes mellitus: Furthermore, MEG3's competitive binding to miR-185-5p as a competing endogenous RNA (ceRNA) has been shown to promote the expression of early growth response 2 (EGR2), which inhibits IRS, and its overexpression in T2D patients has been significant [64,65].